| Filed On | Filing |
|---|---|
| 13 Oct 2026 | 25-NSE |
| 02 Sep 2026 | SCHEDULE 13D/A |
| 24 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 17, 2026, Krishna Gupta, a Class I member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora... |
| 14 Aug 2026 | NT 10-Q |
| 24 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
This letter agreement (the “Agreement”) confirms the agreement of Allurion Technologies, Inc., a Delaware corporation (the “Company”), and the holders of the Common Stock listed on Schedule I attached hereto (the “Stockholders”), pursuan... |
| 23 Jul 2026 | SCHEDULE 13D/A |
| 23 Jul 2026 |
Form 4: Rtw INVESTMENTS, Lp, 10% owner and 1 other
Disposed of 392,766 shares (Other Transaction) · Acquired 392,766 Pre-Funded Warrant (Right to Buy) (Other Transaction) |
| 23 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 17, 2026, Shantanu K. Gaur, M.D. notified Allurion Technologies, Inc. (the “Company”) of his resignation as Chief Executive Officer of the Company and as a member of the Company's board of directors (the “Board”), in each case ef... |
| 07 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora... |
| 30 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 24, 2026, R. Jason Richey, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and his role as the chairperson of the Au... |
| 17 Jun 2026 |
8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
ALLURION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: |
| 27 May 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read Item 4.01 of Allurion Technologies, Inc.'s Form 8-K dated May 27, 2026, and have the following comments: |
| 15 May 2026 | 10-Q |
| 30 Mar 2026 | 10-K |
| 12 Mar 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
Files appeal to NYSE on decision to initiate delisting proceedings |
| 02 Mar 2026 | SCHEDULE 13D/A |
| 02 Mar 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
Allurion Intends to Appeal NYSE Notice of Delisting While Executing Plan to Regain Compliance and Expects to Remain Trading |
| 25 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN... |
| 23 Feb 2026 |
8-K: Regulation FD Disclosure
Approval provides Allurion with access to approximately 80 million Americans with obesity |
| 17 Feb 2026 |
Form 5: Gibbons Brendan M., Chief Legal Officer
Gave up 1,862 shares to cover exercise price or tax ($2.89K) |
Loading...